0001127602-15-025709.txt : 20150824 0001127602-15-025709.hdr.sgml : 20150824 20150824182228 ACCESSION NUMBER: 0001127602-15-025709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150824 FILED AS OF DATE: 20150824 DATE AS OF CHANGE: 20150824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooke Shane CENTRAL INDEX KEY: 0001524823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 151071853 MAIL ADDRESS: STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST. CITY: DUBLIN 2 STATE: L2 ZIP: 00000 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-08-24 0001520262 Alkermes plc. ALKS 0001524823 Cooke Shane CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 President, Alkermes plc Ordinary Shares 2015-08-24 4 M 0 18000 14.60 A 58640 D Ordinary Shares 2015-08-24 4 S 0 1000 53.395 D 57640 D Ordinary Shares 2015-08-24 4 S 0 1200 54.6522 D 56440 D Ordinary Shares 2015-08-24 4 S 0 2500 56.6747 D 53940 D Ordinary Shares 2015-08-24 4 S 0 5661 57.7769 D 48279 D Ordinary Shares 2015-08-24 4 S 0 5107 58.6363 D 43172 D Ordinary Shares 2015-08-24 4 S 0 2532 59.4083 D 40640 D Employee Stock Option (Right to Buy) 14.60 2015-08-24 4 M 0 18000 0 D 2021-10-05 Ordinary Shares 18000 106000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.05 to $53.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.28 to $55.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.01 to $57.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.04 to $58.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.05 to $59.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.0675 to $59.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 10/5/12. /s/ Jennifer Baptiste, attorney-in-fact for Shane Cooke 2015-08-24